4-(3-Pentafluorophenyl-ureido)-benzenesulfonamide

ID: ALA316779

Chembl Id: CHEMBL316779

PubChem CID: 11245996

Max Phase: Preclinical

Molecular Formula: C13H8F5N3O3S

Molecular Weight: 381.28

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: 4-(3-(Perfluorophenyl)Ureido)Benzenesulfonamide | 4-{[(Pentafluorophenyl)Carbamoyl]Amino}Benzenesulfonamide | 4-{[(Pentafluorophenyl)carbamoyl]amino}benzenesulfonamide|CHEMBL316779|3n0n|SCHEMBL673008|IOSBUNBTXXXMFG-UHFFFAOYSA-N|BDBM50146756|4-(3-(Perfluorophenyl)Ureido)Benzenesulfonamide|4-(3-Pentafluorophenyl-ureido)-benzenesulfonamide|Q27464314|P9B

Canonical SMILES:  NS(=O)(=O)c1ccc(NC(=O)Nc2c(F)c(F)c(F)c(F)c2F)cc1

Standard InChI:  InChI=1S/C13H8F5N3O3S/c14-7-8(15)10(17)12(11(18)9(7)16)21-13(22)20-5-1-3-6(4-2-5)25(19,23)24/h1-4H,(H2,19,23,24)(H2,20,21,22)

Standard InChI Key:  IOSBUNBTXXXMFG-UHFFFAOYSA-N

Associated Targets(Human)

CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA9 Tclin Carbonic anhydrase IX (8255 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA12 Tclin Carbonic anhydrase XII (6231 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CA4 Carbonic anhydrase IV (1713 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
mtcA1 Uncharacterized protein Rv1284/MT1322 (182 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PROBABLE TRANSMEMBRANE CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) (107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 381.28Molecular Weight (Monoisotopic): 381.0207AlogP: 2.67#Rotatable Bonds: 3
Polar Surface Area: 101.29Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 9.34CX Basic pKa: CX LogP: 2.44CX LogD: 2.43
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.43Np Likeness Score: -1.62

References

1. de Leval X, Ilies M, Casini A, Dogné JM, Scozzafava A, Masini E, Mincione F, Starnotti M, Supuran CT..  (2004)  Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.,  47  (11): [PMID:15139757] [10.1021/jm031116j]
2. Pacchiano F, Carta F, Vullo D, Scozzafava A, Supuran CT..  (2011)  Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides.,  21  (1): [PMID:21145236] [10.1016/j.bmcl.2010.11.064]
3. Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A, Dedhar S, Supuran CT..  (2011)  Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis.,  54  (6): [PMID:21361354] [10.1021/jm101541x]
4. Lomelino CL, Mahon BP, McKenna R, Carta F, Supuran CT..  (2016)  Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.,  24  (5): [PMID:26810836] [10.1016/j.bmc.2016.01.019]

Source